These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22922005)

  • 1. Post-translational modification of the RhoGTPase activating protein 21, ARHGAP21, by SUMO2/3.
    Bigarella CL; Ferro KP; Barcellos KS; Martins-de-Souza D; Traina F; Novello JC; Saad ST; Archangelo LF
    FEBS Lett; 2012 Sep; 586(19):3522-8. PubMed ID: 22922005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
    Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
    Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative nuclear localization signal of the human RAD52 protein is a potential sumoylation site.
    Saito K; Kagawa W; Suzuki T; Suzuki H; Yokoyama S; Saitoh H; Tashiro S; Dohmae N; Kurumizaka H
    J Biochem; 2010 Jun; 147(6):833-42. PubMed ID: 20190268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.
    Liu J; Sha M; Wang Q; Ma Y; Geng X; Gao Y; Feng L; Shen Y; Shen Y
    BMC Cancer; 2015 Oct; 15():675. PubMed ID: 26458400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO assay with peptide arrays on solid support: insights into SUMO target sites.
    Schwamborn K; Knipscheer P; van Dijk E; van Dijk WJ; Sixma TK; Meloen RH; Langedijk JP
    J Biochem; 2008 Jul; 144(1):39-49. PubMed ID: 18344540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of HSP27 by small ubiquitin-like modifier 2/3 promotes proliferation and invasion of hepatocellular carcinoma cells.
    Ge H; Du J; Xu J; Meng X; Tian J; Yang J; Liang H
    Cancer Biol Ther; 2017 Aug; 18(8):552-559. PubMed ID: 28665748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.
    Sang J; Yang K; Sun Y; Han Y; Cang H; Chen Y; Shi G; Wang K; Zhou J; Wang X; Yi J
    Biochem J; 2011 Apr; 435(2):489-98. PubMed ID: 21291420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARHGAP21 modulates FAK activity and impairs glioblastoma cell migration.
    Bigarella CL; Borges L; Costa FF; Saad ST
    Biochim Biophys Acta; 2009 May; 1793(5):806-16. PubMed ID: 19268501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.
    Yuan Y; Gaither K; Kim E; Liu E; Hu M; Lengel K; Qian D; Xu Y; Wang B; Knipprath H; Liu DX
    J Biol Chem; 2018 Feb; 293(8):2939-2948. PubMed ID: 29326161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumoylation differentially regulates Goosecoid-mediated transcriptional repression.
    Izzi L; Narimatsu M; Attisano L
    Exp Cell Res; 2008 Apr; 314(7):1585-94. PubMed ID: 18336814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells.
    Bursomanno S; Beli P; Khan AM; Minocherhomji S; Wagner SA; Bekker-Jensen S; Mailand N; Choudhary C; Hickson ID; Liu Y
    DNA Repair (Amst); 2015 Jan; 25():84-96. PubMed ID: 25497329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of nuclear actin.
    Hofmann WA; Arduini A; Nicol SM; Camacho CJ; Lessard JL; Fuller-Pace FV; de Lanerolle P
    J Cell Biol; 2009 Jul; 186(2):193-200. PubMed ID: 19635839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRET-based in vitro assays for the analysis of SUMO protease activities.
    Tatham MH; Hay RT
    Methods Mol Biol; 2009; 497():253-68. PubMed ID: 19107423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for high accuracy sumoylation site prediction from protein sequences.
    Xu J; He Y; Qiang B; Yuan J; Peng X; Pan XM
    BMC Bioinformatics; 2008 Jan; 9():8. PubMed ID: 18179724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human SUMO fusion systems enhance protein expression and solubility.
    Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
    Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome-wide identification of SUMO2 modification sites.
    Tammsalu T; Matic I; Jaffray EG; Ibrahim AFM; Tatham MH; Hay RT
    Sci Signal; 2014 Apr; 7(323):rs2. PubMed ID: 24782567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific characterization of endogenous SUMOylation across species and organs.
    Hendriks IA; Lyon D; Su D; Skotte NH; Daniel JA; Jensen LJ; Nielsen ML
    Nat Commun; 2018 Jun; 9(1):2456. PubMed ID: 29942033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover.
    Hardeland U; Steinacher R; Jiricny J; Schär P
    EMBO J; 2002 Mar; 21(6):1456-64. PubMed ID: 11889051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of the SUMOylation machinery in plants.
    Lois LM
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):60-4. PubMed ID: 20074036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.